Hypotensive effects of 8-hydroxy-2-(di-n-propylamino)tetralin and 5-methylurapidil following stereotaxic microinjection into the ventral medulla of the rat
- PMID: 1972893
- PMCID: PMC1917564
- DOI: 10.1111/j.1476-5381.1990.tb12994.x
Hypotensive effects of 8-hydroxy-2-(di-n-propylamino)tetralin and 5-methylurapidil following stereotaxic microinjection into the ventral medulla of the rat
Abstract
1. The effects of the 5-HT1a receptor agonists 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and 5-methylurapidil (5-MU) on blood pressure and heart rate were investigated in the anaesthetized normotensive rat after local injection into the ventral medulla (medial part of the area of the B1/B3 cell group). 2. Both 8-OH-DPAT and 5-MU, decreased arterial blood pressure and heart rate. Local injection of the alpha 1-adrenoceptor antagonist prazosin did not affect cardiovascular parameters. 3. Subcutaneous injection of the 5-HT1a receptor antagonists spiroxatrine or spiperone inhibited the cardiovascular response to 8-OH-DPAT and 5-MU. 4. Histological examination showed the injection sites which were associated with cardiovascular responses to the agonists to be contained within the medial part of the area of the B1/B3 cell group, corresponding to the region of the nucleus raphe magnus and pallidus. Injections of agonists into adjacent areas had no effect on blood pressure or heart rate. 5. The results support the hypothesis that activation of somatodendritic 5-HT1a autoreceptors located on 5-hydroxytryptaminergic neurones in the ventral medulla of the rat results in a decrease in blood pressure and heart rate. The region of the B1/B3 cell group is suggested as a possible site for the hypotensive action of 5-HT1a receptor agonists.
Similar articles
-
Influence of urapidil and 8-OH-DPAT on brain 5-HT turnover and blood pressure in rats.J Cardiovasc Pharmacol. 1990;15 Suppl 7:S68-74. J Cardiovasc Pharmacol. 1990. PMID: 1702489
-
Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis.J Cardiovasc Pharmacol. 1987 Mar;9(3):328-47. doi: 10.1097/00005344-198703000-00010. J Cardiovasc Pharmacol. 1987. PMID: 2437400
-
Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat.Eur J Pharmacol. 1990 May 16;180(2-3):339-49. doi: 10.1016/0014-2999(90)90319-2. Eur J Pharmacol. 1990. PMID: 2142096
-
Involvement of brain 5-HT1A receptors in the hypotensive response to urapidil.Am J Cardiol. 1989 Aug 15;64(7):7D-10D. doi: 10.1016/0002-9149(89)90688-7. Am J Cardiol. 1989. PMID: 2569265 Review.
-
Evidence for the interaction of urapidil with 5-HT1A receptors in the brain leading to a decrease in blood pressure.Am J Cardiol. 1989 Feb 2;63(6):36C-39C. doi: 10.1016/0002-9149(89)90404-9. Am J Cardiol. 1989. PMID: 2643854 Review.
Cited by
-
Central administration of 5-HT activates 5-HT1A receptors to cause sympathoexcitation and 5-HT2/5-HT1C receptors to release vasopressin in anaesthetized rats.Br J Pharmacol. 1992 Dec;107(4):1020-8. doi: 10.1111/j.1476-5381.1992.tb13401.x. Br J Pharmacol. 1992. PMID: 1467825 Free PMC article.
-
Effects of intracerebroventricular injections of 5-HT on systemic vascular resistances of conscious rats.Microvasc Res. 2014 Sep;95:116-23. doi: 10.1016/j.mvr.2014.08.002. Epub 2014 Aug 14. Microvasc Res. 2014. PMID: 25128748 Free PMC article.
-
Serotonin and blood pressure regulation.Pharmacol Rev. 2012 Apr;64(2):359-88. doi: 10.1124/pr.111.004697. Epub 2012 Mar 8. Pharmacol Rev. 2012. PMID: 22407614 Free PMC article. Review.
-
Pressor effects following microinjection of 5-HT1A receptor agonists into the raphe obscurus of the anaesthetized rat.Br J Pharmacol. 1991 Feb;102(2):317-22. doi: 10.1111/j.1476-5381.1991.tb12172.x. Br J Pharmacol. 1991. PMID: 1673069 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials